Market Analysis of Triple-Negative Breast Cancer Treatment

Healtcareresearch26 Nov, 2021Health

Triple-negative breast cancer (TNBC) doesn?t have estrogen or progesterone receptors and also doesn?t make too much of the HER2 protein. Because the cancer cells lack these proteins, hormone therapy and drugs that target HER2 are not helpful, so chemotherapy (chemo) is the main systemic treatment option. And although TNBC tends to respond well to initial chemo, it tends to come back (recur) more frequently than other breast cancers.